The Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ) is Germany’s largest biomedical research center with a worldwide reputation of excellence in basic and translational cancer research. Established in 1964 as a foundation under public law, the DKFZ today has 3424 staff (870 foreign employees from 86 nations as of June 2024). In 2019, the total budget was 319 million Euros funded by the Federal German Government, the State of Baden-Württemberg and third-party funding. The DKFZ is a member of the Helmholtz Association of German Research Centres – Germany’s largest research organization. The strategic goals of the DKFZ are to contribute towards a better understanding of fundamental processes in cancer and to develop innovative methods of cancer diagnostics and therapy. Research at the DKFZ is divided into five main research programs: Cell Biology and Tumor Biology; Functional and Structural Genomics; Cancer Risk Factors and Prevention; Immunology, Infection and Cancer; Imaging and Radiooncology.